As Xenopus eIF4G has not been cloned, we used a human eIF4GI cDNA [3] in our studies. Furthermore, the amino-acid sequence of the eIF4G-binding region in PABP is highly conserved between human and Xenopus. The PABP-binding region in eIF4GI spans amino acids 132-160 (Figure 1a) . Previously, we generated an eIF4GI mutant by converting the amino acids 134 KRERK 138 in the PABP-binding region to alanines (Figure 1a ). This mutation reduces the PABP-binding activity of eIF4GI significantly but not completely [3] . When an additional four amino acids ( 144 DPNQ 147 ) were changed to alanines (Figure 1a) , binding of eIF4GI to PABP was abrogated in Xenopus oocytes (Figure 1d ) and in HeLa cells (data not shown). To facilitate the detection of human eIF4GI in Xenopus oocyte, the FLAG epitope sequence was fused to (d) Co-immunoprecipitation of expressed eIF4GI with associated proteins using anti-FLAG antibody. Oocytes were injected with 30 ng mRNA encoding eIF4GIwt or eIF4GImut. Each lane contains protein from 10 oocytes. The anti-PABP and anti-eIF4A antibodies were described previously [3, 15] . (e) Interaction of eIF4GI with eIF4E. Oocytes were injected with 30 ng eIF4GIwt or eIF4GImut mRNA and 5 ng HA-tagged eIF4E mRNA [15] , and the co-immunoprecipitation experiment was performed as described in (d).
As Xenopus eIF4G has not been cloned, we used a human eIF4GI cDNA [3] in our studies. Furthermore, the amino-acid sequence of the eIF4G-binding region in PABP is highly conserved between human and Xenopus. The PABP-binding region in eIF4GI spans amino acids 132-160 ( Figure 1a ). Previously, we generated an eIF4GI mutant by converting the amino acids 134 KRERK 138 in the PABP-binding region to alanines (Figure 1a ). This mutation reduces the PABP-binding activity of eIF4GI significantly but not completely [3] . When an additional four amino acids ( 144 DPNQ 147 ) were changed to alanines (Figure 1a) , binding of eIF4GI to PABP was abrogated in Xenopus oocytes (Figure 1d ) and in HeLa cells (data not shown). To facilitate the detection of human eIF4GI in Xenopus oocyte, the FLAG epitope sequence was fused to Expression of human eIF4GI in Xenopus oocytes. (a) Schematic diagram of human wild-type and mutant eIF4GI proteins. The binding sites for PABP, eIF4E, eIF3 and eIF4A are indicated. The amino-acid sequence of the PABP-binding site is shown below. Amino-acid residues that were changed to alanines in the mutant protein are underlined. (b) Uninjected oocytes (control), or oocytes injected with 50 ng mRNA encoding eIF4GIwt or eIF4GImut were metabolically labeled with [ 35 S]methionine at 1 mCi/ml for 20 h. Total proteins extracted from the oocytes were resolved by SDS-PAGE and visualized by autoradiography. Each lane contains proteins equivalent to 0.2 oocytes. (c) Western blot analysis. Each lane contains protein equivalent to 0.4 oocytes. Rabbit anti-eIF4GI antibody was prepared against a glutathione-S-transferase (GST)-eIF4GI (amino acids 132-160) fusion protein, which was bacterially expressed. (d) Co-immunoprecipitation of expressed eIF4GI with associated proteins using anti-FLAG antibody. Oocytes were injected with 30 ng mRNA encoding eIF4GIwt or eIF4GImut. Each lane contains protein from 10 oocytes. The anti-PABP and anti-eIF4A antibodies were described previously [3, 15] . (e) Interaction of eIF4GI with eIF4E. Oocytes were injected with 30 ng eIF4GIwt or eIF4GImut mRNA and 5 ng HA-tagged eIF4E mRNA [15] , and the co-immunoprecipitation experiment was performed as described in (d). (Figure 1b,c) . Two different antibodies were used to detect eIF4GI. An antibody against the PABP-binding region (amino acids 132-160) in human eIF4GI recognized both human eIF4GI and endogenous Xenopus eIF4G (Figure 1c, upper panel) . As the amino-acid sequence in the PABP-binding region in human eIF4GI and eIF4GII are conserved [3] , the putative Xenopus eIF4GI and eIF4GII should also be detected with the same antibody. Human eIF4GI (arrow) migrated faster than endogenous eIF4G. The antibody recognized eIF4GImut, although weakly compared with the wildtype protein. The antibody probably recognized the portion of the PABP-binding region that was not mutated. The expressed eIF4GI was also detected using anti-FLAG antibody (Figure 1c , lower panel).
To determine whether human eIF4GI functions in oocytes, the interaction between eIF4GI and endogenous PABP was first examined. Extracts were prepared from oocytes injected with eIF4GIwt or eIF4GImut mRNAs, followed by immunoprecipitation of the expressed eIF4GIs using anti-FLAG antibody. As a control for eIF4GI function, which is not expected to be affected by the mutation, we examined eIF4A and eIF4E binding. Both eIF4GIwt and eIF4GImut interacted with endogenous eIF4A to the same extent, as detected by western analysis (Figure 1d ). In contrast, endogenous PABP associated with eIF4GIwt but not with eIF4GImut ( Figure 1d ). These results demonstrate that human eIF4GI binds to Xenopus PABP, and mutations in the PABP-binding region abolish this interaction. The interaction of eIF4GI with eIF4E was also examined by injecting eIF4GI mRNA together with mRNA encoding hemagglutinin epitope (HA)-tagged eIF4E into oocytes (HA-tagged eIF4E was used because endogenous eIF4E comigrates with the immunoglobulin light chain). A co-immunoprecipitation experiment demonstrated that the mutation in the PABPbinding region did not alter the interaction of eIF4GI with eIF4E ( Figure 1e ).
To examine the effect of eIF4GIwt and eIF4GImut on translation of polyadenylated versus non-adenylated mRNAs, a translation assay with a luciferase reporter mRNA was performed. A capped luciferase mRNA containing either a 98-nucleotide poly(A) tail (A98) or lacking a poly(A) tail (A0) was used. Oocytes were injected with eIF4GI mRNAs and incubated for 18-20 hours, followed by injection with luciferase mRNA and incubation for an additional 4 hours (see Supplementary material). The poly(A) tail stimulated luciferase synthesis both in oocytes expressing eIF4GIwt and in control oocytes that were not injected with eIF4GIwt mRNA (~10-fold and 25-fold, respectively ; Figure 2a , compare sample groups 1,4, and 3,6; three experiments were done with A98 mRNA and two with A0 mRNA). Expression of eIF4GIwt had no significant effect on translation of A98 mRNA (Figure 2a, compare 1,3) . In contrast, the expression of eIF4GImut decreased translation of A98 mRNA (36-57% of that in oocytes expressing eIF4GIwt, compare sample groups 1,2; because the effect of eIF4GImut on translation of A98 mRNA is dependent on the amount of expressed eIF4GImut compared with endogenous eIF4G, the expression of eIF4GImut might not be sufficient to abrogate the effect of the poly(A) tail). There was no significant difference in expression levels of eIF4GIwt and eIF4GImut in this experiment (data not shown). Significantly, neither eIF4GIwt nor eIF4GImut decreased translation of A0 mRNA (compare sample groups 4-6), which indicates that the mutation in the PABP-binding region did not affect the interaction of eIF4GI with other initiation factors. Expression of eIF4GIwt or eIF4GImut modestly stimulated translation of A0 mRNA. RNA analysis demonstrated that all mRNAs exhibited similar stability (see Supplementary material), indicating that the difference in luciferase activity reflects changes in translation. These results demonstrate that eIF4GImut inhibits poly(A)-dependent translation in Xenopus oocytes, most probably by acting as a dominant-negative inhibitor.
Figure 2
The eIF4GI mutant inhibits translation of polyadenylated, but not nonadenylated mRNAs. For the luciferase assay, luminescence was measured and normalized by quantifying the radioactivity of 32 P-labeled luciferase mRNA. One to two pools of five oocytes were collected for each sample. Values are relative to those obtained with oocytes injected with eIF4GIwt and A98 mRNAs, which were set at 100 (sample group 1). The amount of mRNA injected into each oocyte was: eIF4GIwt or eIF4GImut, 60 ng for the experiment represented by the dark grey bars or 30 ng for the other two experiments; luciferase (A0 or A98), 0.3-0.4 ng (~2,000 cpm). M u t a n t C o n t r o l W i l d t y p e M u t a n t C o n t r o l Progesterone-induced Xenopus oocyte maturation can be assessed by the appearance of a characteristic white spot at the animal pole, indicating germinal vesicle breakdown (GVBD). As poly(A)-tail elongation of certain mRNAs is necessary for activation of translation and concomitant oocyte maturation [5, 6] , our results predict that expression of eIF4GImut should result in inhibition of oocyte maturation. To test this prediction, oocytes expressing eIF4GIwt or eIF4GImut were incubated for 8-23 hours in the presence of progesterone. Strikingly, the expression of eIF4GImut dramatically inhibited maturation (a representative result is shown in Figure 3a) . Only 10% of the oocytes expressing eIF4GImut underwent GVBD, whereas about 70% of the oocytes expressing eIF4GIwt and 80% of control oocytes underwent GVBD after 23 hours of incubation with progesterone. Expression of eIF4GIwt had no effect on the kinetics of maturation. The eIF4GImut effect was specific, inasmuch as co-expression of eIF4GIwt with eIF4GImut (w + m) strongly mitigated the inhibitory effect of eIF4GImut. As a control, injection of twice the amount of eIF4GIwt (2 × wt) had no effect on maturation.
The accumulation of c-Mos protein, which is necessary for progesterone-induced maturation [11] in oocytes that have undergone GVBD was confirmed by western blot analysis (Figure 3b ). These results strongly support the idea that the interaction between eIF4G and PABP is necessary for translational activation of mRNAs encoding proteins required for oocyte maturation.
Certain maternal mRNAs are polyadenylated in the cytoplasm, and translationally activated concomitant with oocyte maturation. These mRNAs have two distinct signals in their 3′ untranslated regions (UTRs): an AAUAAA sequence, which is a highly conserved nuclear polyadenylation sequence, and a U-rich sequence termed the cytoplasmic polyadenylation element (CPE) [5, 6] . Translational regulation of c-mos mRNA is an established key regulatory step in Xenopus oocyte maturation [11] [12] [13] ; c-mos mRNA possesses a CPE in its 3′ UTR and is polyadenylated during oocyte maturation [12] . Cytoplasmic polyadenylation is critical for c-mos mRNA translation. Indeed, a luciferase reporter mRNA containing the c-mos CPE (Luc/c-mos) is polyadenylated, and its translation is stimulated in Xenopus oocytes in response to progesterone treatment [12] .
To show that the eIF4G-PABP interaction is important for c-mos translational activation and, consequently, oocyte maturation, we examined the effect of eIF4GImut on the translation of Luc/c-mos mRNA in oocytes. Control oocytes and oocytes expressing eIF4GIwt or eIF4GImut were injected with Luc/c-mos mRNA and incubated in the presence or absence of progesterone for 5-7 hours (see Supplementary material). Progesterone stimulated translation in control oocytes (~4.5-fold; Figure 4 , compare bars 1,2), and in eIF4GIwt-expressing oocytes (twofold; Figure 4 , compare bars 3,4). In contrast, the stimulation in eIF4GImut-expressing oocytes was negligible (Figure 4 , compare bars 5,6). The synthesis of luciferase in eIF4GImut-expressing oocytes in the absence of progesterone was about twofold higher than in control oocytes. The reason for this difference is not immediately clear. All luciferase mRNAs exhibited similar stability as determined by gel electrophoresis (data not shown; the possibility, however, that eIF4GImut affects poly(A) tail elongation could not be ruled out from this experiment). The percentage of oocytes that had undergone GVBD was greater than 85% for control oocytes and oocytes expressing eIF4GIwt, whereas it was less than 10% for oocytes expressing eIF4GImut. These results strongly suggest that eIF4GImut, which is defective in PABP binding,
Brief Communication 1149

Figure 3
Expression of the eIF4GI mutant inhibits progesterone-induced maturation. The requirement for intact eIF4G in Xenopus oocyte maturation has been addressed previously [14] . The authors used Coxsackievirus protease 2A to cleave eIF4G in Xenopus oocytes, causing inhibition of Mos expression and progesterone-induced maturation. They also showed that the expression of a non-cleavable form of eIF4G restored Mos-expression. However, while protease 2A cleaves off the amino-terminal portion of eIF4G containing the PABP-binding region, the eIF4G used to restore translation lacked the amino-terminal 156 amino acids, which contains the PABP-binding site [3] . Thus, the restoration of translation by eIF4G in [14] cannot be explained by restoration of the PABP-eIF4G interaction, and therefore the underlying reason for the phenomenon is different from that described in our paper.
Supplementary material
Supplementary material including additional discussion and methodological detail is available at http://current-biology.com/supmat/supmatin.htm.
Figure 4
The eIF4GI mutant inhibits maturation-specific translational activation of Luc/c-mos mRNA. Each oocyte was injected with 30 ng eIF4GIwt or eIF4GImut mRNA and 0.4-0.5 ng (~2,000 cpm) Luc/c-mos mRNA. -P and +P denote the absence and the presence of progesterone, respectively. The graph shows the measurement of luciferase activity generated from injected Luc/c-mos mRNA. Values are relative to that obtained with control oocytes incubated in the absence of progesterone, which was set at 100 (bar 1). Eight oocytes were collected and assayed. Luciferase activity was normalized by quantifying the radioactivity of 32 P-labeled Luc/c-mos mRNA in each sample. The bars depict the mean with standard error from three independent experiments. For bars 2 and 4, lysate was prepared only from oocytes that had undergone GVBD. For bar 6, lysate was prepared from oocytes that had not undergone GVBD. The percentage of GVBD in each group is indicated below the figure. The ratio of luciferase activity observed in mature versus immature oocytes (+P/-P, maximum and minimum from three independent experiments) is also indicated. For each sample, 16-21 oocytes were injected, using oocytes from different frogs for each experiment. 
